Next Generation Pathogen Sequencing for Prediction of Adverse Events

Active, not recruitingOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2026

Conditions

Bloodstream Infection

Trial Locations (1)

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

collaborator

Karius, Inc.

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER

NCT03226158 - Next Generation Pathogen Sequencing for Prediction of Adverse Events | Biotech Hunter | Biotech Hunter